4//SEC Filing
NEIL GARRY ARTHUR 4
Accession 0001578563-25-000197
CIK 0001534120other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 4:01 PM ET
Size
8.7 KB
Accession
0001578563-25-000197
Insider Transaction Report
Form 4
NEIL GARRY ARTHUR
Chief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2025-03-28+64,867→ 64,927 total - Exercise/Conversion
Restricted Stock Units
2025-03-28+64,867→ 129,733 total→ Common Stock (64,867 underlying) - Tax Payment
Common Stock
2025-03-28$8.46/sh−17,787$150,478→ 47,140 total
Footnotes (2)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On August 13, 2024, the Reporting Person was granted 194,600 restricted stock units, vesting 1/3 on March 28, 2025, March 28, 2026, and March 28, 2027, subject to the Reporting Person's continued service on such vesting date.
Documents
Issuer
Avalo Therapeutics, Inc.
CIK 0001534120
Entity typeother
Related Parties
1- filerCIK 0001586785
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 4:01 PM ET
- Size
- 8.7 KB